Biomarin Pharmaceutical (BMRN) Q1 2018 Earnings

22FebConfirmed
Q2 2017
Q3 2017
Q4 2017
Q1 2018
-0.4
-0.29
-0.18
-0.07

Details

Expected EPS
-0.2
Actual EPS
-0.4
Surprise EPS
-0.2
Surprise Percent
+100%

Description

Biomarin Pharmaceutical (BMRN) has reported earnings of -0.4 per share for Q1 2018.

0 Comments

Share your thoughts